Richard Angelo

Richard A. Angelo, PhD, is Principal Scientist, Clinical Research, for Cardinal Health Regulatory Sciences. He has more than 28 years of product development experience in the pharmaceutical, biologic and medical device industries in operational, senior operational, executive leadership and senior consultant roles. Dr. Angelo is currently responsible for clinical research product development services in areas such as clinical program planning; regulatory strategies toward commercialization; Phase 1 to 4 clinical study design, oversight and management; vendor qualification and management; investigator site qualification and management; regulatory, clinical and quality compliance management; regulatory agent services; and management of regulatory submissions.

His industry tenure includes leadership positions in publicly traded US pharmaceutical corporations as well as full-service contract research organizations. He has led regional, national and international multidisciplinary clinical development teams in various therapeutic areas, including infectious diseases, oncology, analgesia and allergy. Dr. Angelo’s expertise helps companies ensure compliance with FDA regulations, harmonized international regulations, industry guidance documents, Good Clinical Practices, Good Clinical Laboratory Practices, Good Pharmacovigilance Practices, clinical study protocols and applicable standard operating procedures pertaining to development and commercialization of drugs, biologics and medical devices. Dr. Angelo was the principal author of chapter 16, “Medical Device Compliance and Postmarketing Activities,” in Fundamentals of US Regulatory Affairs, Seventh Edition, a Regulatory Affairs Professionals Society (RAPS) publication.

Courses Taught